View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Headline News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 21, 2024
3 min read
Save

Mediterranean-style diet may reduce adverse pregnancy outcomes for Black, Hispanic women

Mediterranean-style diet may reduce adverse pregnancy outcomes for Black, Hispanic women

CHICAGO — Black and Hispanic women who adhered to components of a Mediterranean-style diet were less likely to experience any adverse pregnancy outcome, regardless of overweight or obesity status, researchers reported.

SPONSORED CONTENT
November 21, 2024
2 min read
Save

Fasting during night shift better maintains glucose tolerance vs. eating meals, snacks

Fasting during night shift better maintains glucose tolerance vs. eating meals, snacks

Healthy adults who fasted for the entirety of simulated night-shift work displayed compensatory hyperinsulinemia and maintained glucose tolerance compared with participants who consumed a meal or snack, study results showed.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
November 21, 2024
2 min read
Save

Hidradenitis suppurativa linked to adverse maternal, offspring outcomes

Hidradenitis suppurativa linked to adverse maternal, offspring outcomes

Hidradenitis suppurativa was linked to adverse maternal and offspring outcomes during the peripartum period and in the long-term, according to a study.

SPONSORED CONTENT
November 21, 2024
2 min read
Save

Salt substitution at age 40 years cost-effective for high-risk adults with prehypertension

Salt substitution at age 40 years cost-effective for high-risk adults with prehypertension

Salt substitution intervention beginning at age 40 years was cost-effective among Chinese adults with prehypertension compared with antihypertensive drug treatment alone, according to findings published in Hypertension.

SPONSORED CONTENT
November 21, 2024
3 min read
Save

Q&A: Physician aspires to improve outcomes for underserved communities

Q&A: Physician aspires to improve outcomes for underserved communities

Aisha Mohammed, MD, was led to the field of medicine with a specific focus on underserved communities after witnessing her mother’s challenges in accessing care.

SPONSORED CONTENT
November 21, 2024
1 min read
Save

Early positive data reported for geographic atrophy modifier gene therapy

Early positive data reported for geographic atrophy modifier gene therapy

OCU410, a single-dose modifier gene therapy, demonstrated positive preliminary outcomes for the treatment of geographic atrophy in a phase 1/2 clinical trial, according to a press release from Ocugen.

SPONSORED CONTENT
November 21, 2024
2 min read
Save

FDA approves Ziihera for advanced HER2-positive biliary tract cancer

FDA approves Ziihera for advanced HER2-positive biliary tract cancer

The FDA granted accelerated approval to zanidatamab-hrii for treatment of adults with previously treated unresectable or metastatic HER2-positive biliary tract cancer.

SPONSORED CONTENT
November 21, 2024
3 min read
Save

Identifying, treating patients with COPD plus diabetes, COPD plus osteoporosis

Identifying, treating patients with COPD plus diabetes, COPD plus osteoporosis

PHILADELPHIA — In addition to COPD, patients frequently have other chronic diseases on top of their lung disease, including type 2 diabetes and osteoporosis, according to a presentation at the 2024 GOLD COPD International Conference.

SPONSORED CONTENT
November 21, 2024
3 min read
Save

‘Promoting honest and accurate conversations’ key before pregnancy in patients with ILD

‘Promoting honest and accurate conversations’ key before pregnancy in patients with ILD

BOSTON — To help patients with interstitial lung disease lower the chances of having a sick baby, physicians must have “honest and accurate conversations” with them before pregnancy, according to a presentation at the CHEST Annual Meeting.

SPONSORED CONTENT
November 21, 2024
2 min read
Save

Combination PEG-INF a-2b therapy achieves higher HBsAg loss in HBV-infected children

Combination PEG-INF a-2b therapy achieves higher HBsAg loss in HBV-infected children

SAN DIEGO — Combination therapy with peginterferon alfa-2b and nucleos(t)ide analogues resulted in significantly higher hepatitis B surface antigen loss vs. monotherapy in children with HBV, especially among those aged younger than 7 years.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails